Preclinical modeling of chronic inhibition of the Parkinson’s disease associated kinase LRRK2 reveals altered function of the endolysosomal system in vivo
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Preclinical modeling of chronic inhibition of the Parkinson’s disease associated kinase LRRK2 reveals altered function of the endolysosomal system in vivo ; volume:16 ; number:1 ; day:19 ; month:3 ; year:2021 ; pages:1-19 ; date:12.2021
Molecular neurodegeneration ; 16, Heft 1 (19.3.2021), 1-19, 12.2021
- Creator
-
Kluss, Jillian H.
Mazza, Melissa Conti
Li, Yan
Manzoni, Claudia
Lewis, Patrick A.
Cookson, Mark R.
Mamais, Adamantios
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13024-021-00441-8
- URN
-
urn:nbn:de:101:1-2021050520441860834216
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kluss, Jillian H.
- Mazza, Melissa Conti
- Li, Yan
- Manzoni, Claudia
- Lewis, Patrick A.
- Cookson, Mark R.
- Mamais, Adamantios
- SpringerLink (Online service)
Other Objects (12)
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
Rab29 activation of the Parkinson's disease‐associated LRRK2 kinase
Pathogenic Mutation of Lrrk2 : A Mouse Model for pre-motor Parkinson’s disease
Lysosomal Pathogenesis of Parkinson’s Disease: Insights From LRRK2 and GBA1 Rodent Models
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
Altered dynamics of visual contextual interactions in Parkinson’s disease
Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson’s disease
Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2 G2019S -Parkinson’s disease
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
Rab29 activation of the Parkinson's disease‐associated LRRK2 kinase
Pathogenic Mutation of Lrrk2 : A Mouse Model for pre-motor Parkinson’s disease
Lysosomal Pathogenesis of Parkinson’s Disease: Insights From LRRK2 and GBA1 Rodent Models
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
Altered dynamics of visual contextual interactions in Parkinson’s disease
Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson’s disease
Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2 G2019S -Parkinson’s disease
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
Rab29 activation of the Parkinson's disease‐associated LRRK2 kinase
Pathogenic Mutation of Lrrk2 : A Mouse Model for pre-motor Parkinson’s disease
Lysosomal Pathogenesis of Parkinson’s Disease: Insights From LRRK2 and GBA1 Rodent Models
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
Altered dynamics of visual contextual interactions in Parkinson’s disease
Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson’s disease